MCK
February 7, 2024 - AI Summary
Undervalued by 38.2% based on the discounted cash flow analysis.
Market cap | $69.68 Billion |
---|---|
Enterprise Value | $73.59 Billion |
Dividend Yield | $2.3971 (0.45%) |
Earnings per Share | $22.11 |
Beta | -0.01 |
Outstanding Shares | 131,408,286 |
Avg 30 Day Volume | 617,572 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 23.24 |
---|---|
PEG | -51.18 |
Price to Sales | 0.24 |
Price to Book Ratio | -34.11 |
Enterprise Value to Revenue | 0.24 |
Enterprise Value to EBIT | 18.96 |
Enterprise Value to Net Income | 24 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | -2.87 |
No data
No data
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, p...